Clinical responses to adoptive T-cell transfer can be modeled in an autologous immune-humanized mouse model
Combining different types of immune therapies might benefit certain patients. Here, the authors develop an autologous immune-humanized melanoma mouse model that allows the preclinical assessment of cancer cell–T cell interactions from each individual patient and the benefits of immunotherapies combi...
Guardado en:
Autores principales: | Henrik Jespersen, Mattias F. Lindberg, Marco Donia, Elin M. V. Söderberg, Rikke Andersen, Ulrich Keller, Lars Ny, Inge Marie Svane, Lisa M. Nilsson, Jonas A. Nilsson |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/872053043156473e8e20cc09cdc48cb0 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
por: Martin Lauss, et al.
Publicado: (2017) -
Author Correction: Mutational and putative neoantigen load predict clinical benefit of adoptive T cell therapy in melanoma
por: Martin Lauss, et al.
Publicado: (2020) -
Rat model of an autologous cancellous bone graft
por: Tomo Hamada, et al.
Publicado: (2021) -
Molecular profiling of driver events in metastatic uveal melanoma
por: Joakim Karlsson, et al.
Publicado: (2020) -
Reactivation in working memory: an attractor network model of free recall.
por: Anders Lansner, et al.
Publicado: (2013)